Jazz Pharmaceuticals PLC (JAZZ)
110.01
+0.72
(+0.66%)
USD |
NASDAQ |
May 03, 16:00
110.07
+0.06
(+0.05%)
After-Hours: 20:00
Jazz Pharmaceuticals Cash from Financing (Quarterly): -56.55M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -56.55M |
December 31, 2023 | -100.31M |
September 30, 2023 | -78.49M |
June 30, 2023 | -96.67M |
March 31, 2023 | -29.79M |
December 31, 2022 | 19.60M |
September 30, 2022 | -289.05M |
June 30, 2022 | 10.78M |
March 31, 2022 | -270.81M |
December 31, 2021 | -246.61M |
September 30, 2021 | -465.18M |
June 30, 2021 | 4.664B |
March 31, 2021 | 18.28M |
December 31, 2020 | 55.88M |
September 30, 2020 | -22.66M |
June 30, 2020 | 642.53M |
March 31, 2020 | -147.68M |
December 31, 2019 | -87.78M |
September 30, 2019 | -19.46M |
June 30, 2019 | -56.15M |
March 31, 2019 | -130.35M |
December 31, 2018 | -446.46M |
September 30, 2018 | -13.97M |
June 30, 2018 | 28.87M |
March 31, 2018 | -47.58M |
Date | Value |
---|---|
December 31, 2017 | -39.98M |
September 30, 2017 | 27.03M |
June 30, 2017 | -214.48M |
March 31, 2017 | -181.67M |
December 31, 2016 | -172.04M |
September 30, 2016 | 895.22M |
June 30, 2016 | -29.74M |
March 31, 2016 | -152.46M |
December 31, 2015 | -123.86M |
September 30, 2015 | -94.42M |
June 30, 2015 | 7.223M |
March 31, 2015 | -3.261M |
December 31, 2014 | -10.44M |
September 30, 2014 | 263.27M |
June 30, 2014 | -39.46M |
March 31, 2014 | 497.66M |
December 31, 2013 | -28.72M |
September 30, 2013 | -45.72M |
June 30, 2013 | 47.46M |
March 31, 2013 | 3.133M |
December 31, 2012 | 3.59M |
September 30, 2012 | -5.488M |
June 30, 2012 | 468.65M |
March 31, 2012 | -18.22M |
December 31, 2011 | 2.801M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-465.18M
Minimum
Sep 2021
4.664B
Maximum
Jun 2021
172.20M
Average
-56.35M
Median
Cash from Financing (Quarterly) Benchmarks
Alkermes PLC | -17.87M |
Endo International PLC | -149.76M |
Medtronic PLC | -1.50B |
Perrigo Co PLC | -44.60M |
Iterum Therapeutics PLC | 0.589M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 267.23M |
Cash from Investing (Quarterly) | -271.90M |
Free Cash Flow | 983.48M |
Free Cash Flow Per Share (Quarterly) | 4.003 |
Free Cash Flow to Equity (Quarterly) | 252.78M |
Free Cash Flow to Firm (Quarterly) | 798.03M |
Free Cash Flow Yield | 12.91% |